Access to biologicals in Crohn’s disease in ten European countries

Table 5 Correlation matrix

	No. of patients on biologicals per 100000 population	Availability score	Affordability ratio	GDP per capita	% of public health expenditure in the total health expenditure	% of general government expenditure in public health expenditure
No. of patients on biologicals per 100000 population	1.0000	-	-	-	-	-
	-0.7497	1.0000	-	-	-	-
Availability score	(P = 0.0125)	-	-	-	-	-
Affordability ratio	-0.6920	0.5989	1.0000	-	-	-
	(P = 0.0266)	(P = 0.0673)	-			-
GDP per capita	0.9077	-0.8810	-0.7464	1.0000	-	-
	(P = 0.0003)	(P = 0.0008)	(P = 0.0132)	-	-	-
% of public health expenditure in the total health expenditure	0.3879	-0.5338	-0.1553	0.4907	1.0000	-
	(P = 0.2680)	(P = 0.1120)	(P = 0.6683)	(P = 0.149)	-	-
% of general government expenditure in public health expenditure	0.6661	-0.4384	-0.3741	0.4233	0.1547	1.0000
	(P = 0.0713)	(P = 0.2772)	(P = 0.3612)	(P = 0.296)	(P = 0.7146)	-

Sources: Population, GDP per capita (2014): The World Bank, % of public health expenditure in the total health expenditure (2015): The World Bank, European health for all database; % of general government expenditure in the total public health expenditure (2013) OECD. GDP: Gross domestic product.